The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Philip N. Sambrook

University of Sydney

Sydney

Australia

[email]@med.usyd.edu.au

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Sydney, Sydney, Australia. 2007 - 2012
  • Department of Rheumatology, Institute of Bone and Joint Research, University of Sydney, Level 4, Australia. 2000 - 2012
  • Kolling Institute, Royal North Shore Hospital, St Leonards, Sydney, Australia. 2010
  • Royal North Shore Hospital, Sydney, Australia. 2000 - 2010
  • Institute of Bone and Joint Research, Department of Public Health, ANZAC Research Institute, University of Sydney, Australia. 2004
  • Sydney University Dept. of Rheumatology, Royal North Shore Hospital, Australia. 2000

References

  1. Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. Sambrook, P.N., Roux, C., Devogelaer, J.P., Saag, K., Lau, C.S., Reginster, J.Y., Bucci-Rechtweg, C., Su, G., Reid, D.M. Bone (2012) [Pubmed]
  2. Carpal tunnel syndrome and its relationship to occupation: a meta-analysis. Barcenilla, A., March, L.M., Chen, J.S., Sambrook, P.N. Rheumatology. (Oxford) (2012) [Pubmed]
  3. Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Sambrook, P.N., Cameron, I.D., Chen, J.S., Cumming, R.G., Durvasula, S., Herrmann, M., Kok, C., Lord, S.R., Macara, M., March, L.M., Mason, R.S., Seibel, M.J., Wilson, N., Simpson, J.M. Osteoporos. Int (2012) [Pubmed]
  4. Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Sambrook, P.N., Cameron, I.D., Chen, J.S., March, L.M., Simpson, J.M., Cumming, R.G., Seibel, M.J. Osteoporos. Int (2011) [Pubmed]
  5. Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA. Sambrook, P., Cranney, A., Adachi, J.D. Curr. Med. Res. Opin (2010) [Pubmed]
  6. Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality. Sambrook, P.N., Chen, J.S., Simpson, J.M., March, L.M. Med. J. Aust. (2010) [Pubmed]
  7. Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw. Sambrook, P.N. Nature Clinical Practice. Rheumatology (2009) [Pubmed]
  8. Osteonecrosis of the jaw. Sambrook, P.N., Ebeling, P. Curr. Rheumatol. Rep (2008) [Pubmed]
  9. Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis? Sambrook, P.N. Nat. Clin. Pract. Endocrinol. Metab (2007) [Pubmed]
  10. Influence of fall related factors and bone strength on fracture risk in the frail elderly. Sambrook, P.N., Cameron, I.D., Chen, J.S., Cumming, R.G., Lord, S.R., March, L.M., Schwarz, J., Seibel, M.J., Simpson, J.M. Osteoporos. Int (2007) [Pubmed]
  11. Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women. Sambrook, P. Clin. Interv. Aging (2007) [Pubmed]
  12. Compliance with treatment in osteoporosis patients--an ongoing problem. Sambrook, P. Aust. Fam. Physician (2006) [Pubmed]
  13. Osteoporosis. Sambrook, P., Cooper, C. Lancet (2006) [Pubmed]
  14. Vitamin D and fractures: quo vadis?. Sambrook, P. Lancet (2005) [Pubmed]
  15. D-hormones for prevention of bone loss after organ transplant. Sambrook, P.N. J. Rheumatol. Suppl (2005) [Pubmed]
  16. Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International. Sambrook, P.N., Geusens, P., Ribot, C., Solimano, J.A., Ferrer-Barriendos, J., Gaines, K., Verbruggen, N., Melton, M.E. J. Intern. Med. (2004) [Pubmed]
  17. Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. Sambrook, P.N., Chen, J.S., March, L.M., Cameron, I.D., Cumming, R.G., Lord, S.R., Zochling, J., Sitoh, Y.Y., Lau, T.C., Schwarz, J., Seibel, M.J. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  18. Alendronate in the prevention of osteoporosis: 7-year follow-up. Sambrook, P.N., Rodriguez, J.P., Wasnich, R.D., Luckey, M.M., Kaur, A., Meng, L., Lombardi, A. Osteoporos. Int (2004) [Pubmed]
  19. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. Sambrook, P.N., Chen, J.S., March, L.M., Cameron, I.D., Cumming, R.G., Lord, S.R., Schwarz, J., Seibel, M.J. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  20. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. Sambrook, P.N., Kotowicz, M., Nash, P., Styles, C.B., Naganathan, V., Henderson-Briffa, K.N., Eisman, J.A., Nicholson, G.C. J. Bone Miner. Res. (2003) [Pubmed]
  21. Once weekly alendronate. Sambrook, P. Drugs. Today (2003) [Pubmed]
  22. Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Sambrook, P.N., Hughes, D.R., Nelson, A.E., Robinson, B.G., Mason, R.S. Ann. Rheum. Dis. (2003) [Pubmed]
  23. Steroid-induced osteoporosis. Sambrook, P.N. Ann. Acad. Med. Singap. (2002) [Pubmed]
  24. Corticosteroid osteoporosis. Sambrook, P.N. Z. Rheumatol (2000) [Pubmed]
  25. Osteoporosis prevention and treatment. Sambrook, P.N., Eisman, J.A. Med. J. Aust. (2000) [Pubmed]
  26. Postmenopausal osteoporosis treatment guidelines. Sambrook, P., O'Neill, S., Diamond, T., Flicker, L., MacLennan, A. Aust. Fam. Physician (2000) [Pubmed]
 
WikiGenes - Universities